We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1.48%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$218B
AUM Growth
+$27.7B
(+15%)
Cap. Flow
+$35.3B
Cap. Flow
% of AUM
16.16%
Top 10 Holdings %
Top 10 Hldgs %
11.23%
Holding
3,840
New
278
Increased
2,380
Reduced
985
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.58B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
Costco
COST
|
+$680M |
| 4 |
Booking.com
BKNG
|
+$647M |
| 5 |
Broadcom
AVGO
|
+$559M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$355M |
| 2 |
Walmart Inc
WMT
|
+$348M |
| 3 |
Zoom
ZM
|
+$321M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
Lyft
LYFT
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.29% |
| 2 | Financials | 14.55% |
| 3 | Industrials | 13.75% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Healthcare | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Quantum Computing Inc
QUBT
$1.97B
| $110K | ﹤0.01% |
16,077
-21,196
| -57% | -$194K |
|
3677
Neumora Therapeutics
NMRA
$304M
| $109K | ﹤0.01% |
55,995
-38,175
| -41% | -$98.9K |
|
3678
Superior Group of Companies
SGC
$202M
| $109K | ﹤0.01% |
+10,709
| New | +$108K |
|
3679
Arbutus Biopharma
ABUS
$861M
| $107K | ﹤0.01% |
23,819
+7,036
| +42% | +$30.8K |
|
3680
Cardiff Oncology
CRDF
$72.7M
| $107K | ﹤0.01% |
+66,156
| New | +$136K |
|
3681
Evolus
EOLS
$398M
| $106K | ﹤0.01% |
25,677
+2,700
| +12% | +$13.1K |
|
3682
ASP Isotopes
ASPI
$521M
| $105K | ﹤0.01% |
23,797
-5,559
| -19% | -$32.9K |
|
3683
Lakeland Industries
LAKE
$117M
| $101K | ﹤0.01% |
+12,320
| New | +$111K |
|
3684
Enovix
ENVX
$921M
| $96.6K | ﹤0.01% |
18,647
+7,787
| +72% | +$48.7K |
|
3685
Ispire Technology
ISPR
$93M
| $96.1K | ﹤0.01% |
52,219
+27,210
| +109% | +$70.3K |
|
3686
Southland Holdings
SLND
$32.5M
| $94.3K | ﹤0.01% |
72,504
+57,409
| +380% | +$103K |
|
3687
Richtech Robotics
RR
$340M
| $92.4K | ﹤0.01% |
44,221
-12,548
| -22% | -$38.6K |
|
3688
flyExclusive
FLYX
$62.1M
| $91.6K | ﹤0.01% |
+40,521
| New | +$117K |
|
3689
Geron
GERN
$821M
| $89.2K | ﹤0.01% |
59,847
+15,461
| +35% | +$23.5K |
|
|
IAUX
3690
i-80 Gold Corp
IAUX
$1.16B
| $89.1K | ﹤0.01% |
+58,612
| New | +$100K |
|
3691
Candel Therapeutics
CADL
$738M
| $88.3K | ﹤0.01% |
+18,028
| New | +$98.1K |
|
3692
IHS Holding
IHS
$2.78B
| $87.7K | ﹤0.01% |
+10,654
| New | +$85.3K |
|
3693
Blue Ridge Bankshares
BRBS
$323M
| $84.9K | ﹤0.01% |
20,225
-1,200
| -6% | -$5.02K |
|
3694
Plug Power
PLUG
$2.9B
| $84.2K | ﹤0.01% |
38,441
+13,703
| +55% | +$29.7K |
|
3695
Riskified
RSKD
$698M
| $78.4K | ﹤0.01% |
+19,991
| New | +$88.6K |
|
|
LFT
3696
Lument Finance Trust
LFT
$35.9M
| $77.7K | ﹤0.01% |
61,659
+51,081
| +483% | +$69.1K |
|
3697
DiaMedica Therapeutics
DMAC
$351M
| $76.4K | ﹤0.01% |
11,287
-24,478
| -68% | -$194K |
|
3698
Stoneridge
SRI
$210M
| $76.3K | ﹤0.01% |
15,798
-9,945
| -39% | -$68.2K |
|
|
ACTU
3699
Actuate Therapeutics
ACTU
$25.4M
| $74.3K | ﹤0.01% |
+27,109
| New | +$112K |
|
|
XRXDW
3700
Xerox Holdings Corp Warrants
XRXDW
$24.7M
| $73.7K | ﹤0.01% |
+813,971
| New | +$89.6K |
|
Similar funds
AQR Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, AQR Capital Management held 3,840 positions worth $218B, up 15% from $191B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
AQR Capital Management deployed $35.3B of net new capital in Q1 2026, opening 278 new positions and adding to 2,380 existing holdings. Its largest new stake was Versant Media Group: 5,801,568 shares worth $211M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Atlassian, an estimated $355M trimmed.
- AQR Capital Management's largest Q1 2026 buy was Versant Media Group: 5,801,568 shares worth $211M.
- AQR Capital Management added most to Microsoft in Q1 2026, an estimated $1.58B increase.
- AQR Capital Management's biggest Q1 2026 reduction was Atlassian, cutting an estimated $355M.
- AQR Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $226M.
- AQR Capital Management's ten largest holdings make up 11% of its $218B portfolio in Q1 2026.
- AQR Capital Management opened 278 new positions and closed 101 in Q1 2026.
- AQR Capital Management's portfolio value rose 15% quarter-over-quarter to $218B.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.